Janux Therapeutics News

Janux Therapeutics | 424B5: Prospectus

Feb 29 17:35 ET

Janux Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Feb 29 06:09 ET

Janux Therapeutics | 424B5: Prospectus

Feb 28 13:27 ET

Janux Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Sep 7, 2023 18:14 ET

Janux Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Aug 14, 2023 16:33 ET

Janux Therapeutics | 424B5: Prospectus

Jul 18, 2023 17:24 ET

Janux Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Jul 17, 2023 08:16 ET

Janux Therapeutics | 424B5: Prospectus

May 9, 2023 17:07 ET

Janux Therapeutics: Others

EFFECT | Janux Therapeutics, Inc. (0001817713) (Filer)

Sep 20, 2022 00:15 ET

Janux Therapeutics | 424B4: Prospectus

Jun 11, 2021 16:49 ET

Janux Therapeutics | EFFECT: Others

Jun 11, 2021 00:16 ET

Janux Therapeutics | 8-A12B: Registration of a class of securities on a national securities exchange

Jun 9, 2021 16:07 ET